| 产品描述: | ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with Kd of 0.34 nM (37 °C, 2 h). ONO-0300302 can be used for benign prostatic hyperplasia (BPH) research. |
| 靶点: |
LPA1 Receptor:0.086 μM (IC50) |
| 体外研究: |
ONO-0300302 inhibits significantly an LPA (lysophosphatidic acid receptor)-induced increase of intraurethral pressure (IUP) in rat (3 mg/kg, p.o.) and dog (1 mg/kg, p.o.) over 12 h[1]. |
| 体内研究: |
ONO-0300302 shows moderate stability against rat microsomes. |
| 保存条件: |
-20°C, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.094 ml |
10.469 ml |
20.938 ml |
| 5 mM |
0.419 ml |
2.094 ml |
4.188 ml |
| 10 mM |
0.209 ml |
1.047 ml |
2.094 ml |
| 50 mM |
0.042 ml |
0.209 ml |
0.419 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |